News tagged with journal of experimental medicine
Hitting 'reset' in protein synthesis restores myelination, suggests new treatment for misfolded protein diseases
(Medical Xpress)—A potential new treatment strategy for patients with Charcot-Marie-Tooth disease is on the horizon, thanks to research by neuroscientists now at the University at Buffalo's Hunter James ...
Medical research
Apr 26, 2013 |
4.3 / 5 (4) |
0
|
New agent might control breast-cancer growth and spread
A new study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) suggests that an unusual ...
Cancer
Apr 22, 2013 |
not rated yet |
0
|
Molecule treats leukemia by preventing cancer cell repair, scientists report
(Medical Xpress)—Researchers at The Jackson Laboratory have identified a molecule that prevents repair of some cancer cells, providing a potential new "genetic chemotherapy" approach to cancer treatment ...
Cancer
Apr 17, 2013 |
4.7 / 5 (3) |
0
|
Experimental drug may work against hepatitis C
(HealthDay)—An experimental therapy for hepatitis C—a "silent killer" linked to liver cancer and cirrhosis—has shown promise in tamping down virus levels in early trials.
Diseases, Conditions, Syndromes
Mar 27, 2013 |
5 / 5 (3) |
1
|
T-cell therapy eradicates an aggressive leukemia in two children
Two children with an aggressive form of childhood leukemia had a complete remission of their disease-showing no evidence of cancer cells in their bodies-after treatment with a novel cell therapy that reprogrammed their immune ...
Cancer
Mar 25, 2013 |
5 / 5 (4) |
0
|
Breakthrough in battle against leukemia
Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments.
Cancer
Mar 13, 2013 |
5 / 5 (5) |
0
Novel anti-clotting drug more effective than Plavix in coronary procedures, study says
(Medical Xpress)—An experimental drug has been shown to be significantly more effective at preventing blood clots during coronary stenting procedures compared to the anti-clotting agent now typically used, according to ...
Cardiology
Mar 11, 2013 |
not rated yet |
0
|
Gene identified in some melanoma linked to increased resistance to treatment
(Medical Xpress)—Scientists at Queen Mary, University of London have identified a gene present in some melanoma which appears to make the tumour cells more resistant to treatment, according to research ...
Cancer
Feb 19, 2013 |
5 / 5 (1) |
0
|
Tumor blood vessels prevent the spread of cancer cells
A lack of the protein endoglin in the blood vessels of tumour-bearing mice enables the spread of daughter tumours, according to researchers at Karolinska Institutet and Lund University in Sweden in a study published in the ...
Cancer
Feb 11, 2013 |
not rated yet |
0
The skin aging regulator
Despite progress in regenerative medicine, with age, the skin loses its properties in an irreversible manner. The ATIP-Avenir team "Epidermal homeostasis and tumorigenesis" directed by Chloé Féral, an Inserm ...
Medical research
Jan 22, 2013 |
5 / 5 (2) |
0
Cellular metabolism arms T cells to battle viruses and tumours
(Medical Xpress)—New research demonstrates that the cellular metabolism of certain immune cells is closely linked to their function, which includes protecting against viral infections and the development of tumours.
Medical research
Dec 24, 2012 |
5 / 5 (4) |
0
|
Surviving sepsis with LECT2
Failure to launch an adequate immune response may be at the root of septic shock, according to a study published in The Journal of Experimental Medicine on December 17th.
Medical research
Dec 17, 2012 |
not rated yet |
0
(Antibody) orientation matters
The orientation of antibody binding to bacteria can mean life or death to the bug, according to a study published in The Journal of Experimental Medicine on December 10th. These findings may help explain why these bacter ...
Medical research
Dec 10, 2012 |
4 / 5 (1) |
0
Dermatitis could be suppressed as it develops
Excessive immune reactions against the body's own skin cells can lead to painful and even chronic dermatitis. An international team of researchers at the MedUni Vienna, the MedUni Graz and the Salk Institute ...
Immunology
Nov 09, 2012 |
5 / 5 (1) |
0
Mouse model exposes a new type of T cell to target melanoma
Cancers arise in the body all the time. Most are nipped in the bud by the immune response, not least by its T cells, which detect telltale molecular markers—or antigens—on cancer cells and destroy them before they grow ...
Cancer
Oct 24, 2012 |
not rated yet |
0
Journal of Experimental Medicine
The Journal of Experimental Medicine is a peer-reviewed academic journal that publishes research papers and commentaries in the biomedical area. Topics covered include immunology, inflammation, infectious disease, hematopoiesis, cancer, stem cells and vascular biology. The journal has a history of predominantly publishing basic research, although studies in human subjects form an increasing proportion of papers published (around 10% in 2004).
JEM was founded in 1896, which makes it among the longest established of scientific journals. Initially published at the Johns Hopkins University, it was taken over in 1905 by the Rockefeller University Press, the current publishers, and is published on a not-for-profit basis. There is no single Editor-in-Chief, with eleven academic Editors and a hundred strong Advisory Board.
JEM is published monthly. An online archive of articles back to 1896 is available in text and PDF formats (material from 1996 and earlier is only available in PDF). Material over 6 months old is freely accessible, and access to all papers is also provided free of charge to developing countries. All of the content of JEM is also deposited in PubMed Central where it is available to the public 6 months after publication. Copyright to articles remains with the authors and third parties may re-use JEM content under the terms of a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license described at http://creativecommons.org/licenses/by-nc-sa/3.0/.
For more information about Journal of Experimental Medicine, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
